Topic: The Lancet
A synthetic steroid used to treat menopause symptoms and prevent osteoporosis significantly increases the risk of a relapse in breast cancer patients, according to a study released Tuesday. The steroid, called tibolone, should not be prescribed to a woman who has had ...
